Literature DB >> 15693652

Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders.

Hongming Zhuang1, Jian Q Yu, Abass Alavi.   

Abstract

FDG-PET has great potential in the evaluation of a variety of inflammatory and infectious disorders and possibly other benign disorders. FDG-PET is very helpful in the evaluation of chronic osteomyelitis, sarcoidosis, FUO, and differentiating toxoplasmosis from lymphoma in the central nervous system in HIV-positive patients. The assessment of efficacy of FDG-PET in the evaluation of arthroplasty-associated infection, large-vessel vasculitis, and other inflammatory and infectious disorders is ongoing but seems quite promising at this time.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15693652     DOI： 10.1016/j.rcl.2004.07.005

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN： 0033-8389            Impact factor:   2.303


  35 in total

1.  Staging with PET and the "Will Rogers" effect: redefining prognosis and survival in patients with cancer.

Authors:  Sandip Basu; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01       Impact factor: 9.236

2.  A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET).

Authors:  Laura Belloli; Marcello Rodari; Marco Massarotti; Luisa Conciato; Arturo Chiti; Bianca Marasini
Journal:  Clin Rheumatol       Date:  2008-01-12       Impact factor: 2.980

3.  Disseminated tuberculosis infection: a 'super' 18F-FDG PET/CT appearance.

Authors:  Abdul Jalil Nordin; Claudio Rossetti; Noraini Abdul Rahim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-19       Impact factor: 9.236

4.  Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?

Authors:  Abass Alavi; Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

5.  Monitoring of systemic candidiasis by 18F-FDG PET/CT.

Authors:  John Avet; Denise Granjon; Nathalie Prevot-Bitot; Vanina Isnardi; Claire Berger; Jean Louis Stephan; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11       Impact factor: 9.236

6.  Differentiating osteoradionecrosis from nasopharyngeal carcinoma tumour recurrence using ⁹⁹Tcm-sestamibi SPECT/CT.

Authors:  A E H Tan; D C E Ng
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

7.  Assessment of Therapy Response by (18)F-FDG PET/CT for a Patient with Cutaneous and Subcutaneous Mycobacterium Infection and Coexisting Lymphoma.

Authors:  Yang Lu
Journal:  Nucl Med Mol Imaging       Date:  2014-12-11

Review 8.  Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Rakesh Kumar; Sandip Basu; Drew Torigian; Vivek Anand; Hongming Zhuang; Abass Alavi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarate.

Authors:  T H Witney; M I Kettunen; D-e Hu; F A Gallagher; S E Bohndiek; R Napolitano; K M Brindle
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

Review 10.  The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.

Authors:  Yehuda Edo Paz; Sabahat Bokhari
Journal:  Int J Cardiovasc Imaging       Date:  2013-11-30       Impact factor: 2.357
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.